386 related articles for article (PubMed ID: 23392293)
21. Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controlled trial.
Montorsi M; Zerbi A; Bassi C; Capussotti L; Coppola R; Sacchi M;
Ann Surg; 2012 Nov; 256(5):853-9; discussion 859-60. PubMed ID: 23095631
[TBL] [Abstract][Full Text] [Related]
22. Risk factors of pancreatic fistula after pancreaticoduodenectomy - patients with low drain amylase level on postoperative day 1 are safe from developing pancreatic fistula.
Tsujie M; Nakamori S; Miyamoto A; Yasui M; Ikenaga M; Hirao M; Fujitani K; Mishima H; Tsujinaka T
Hepatogastroenterology; 2012; 59(120):2657-60. PubMed ID: 22497944
[TBL] [Abstract][Full Text] [Related]
23. Analysis of risk factors for postoperative pancreatic fistula following pancreaticoduodenectomy.
Liu QY; Zhang WZ; Xia HT; Leng JJ; Wan T; Liang B; Yang T; Dong JH
World J Gastroenterol; 2014 Dec; 20(46):17491-7. PubMed ID: 25516663
[TBL] [Abstract][Full Text] [Related]
24. Are somatostatin or its synthetic analogues helpful in reducing pancreatic fistula?
Angst E; Gloor B
Dig Surg; 2012; 29(6):492-3. PubMed ID: 23392316
[No Abstract] [Full Text] [Related]
25. Histomorphological features of the pancreatic remnant as independent risk factors for postoperative pancreatic fistula: a matched-pairs analysis.
Belyaev O; Munding J; Herzog T; Suelberg D; Tannapfel A; Schmidt WE; Mueller CA; Uhl W
Pancreatology; 2011; 11(5):516-24. PubMed ID: 22056514
[TBL] [Abstract][Full Text] [Related]
26. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
[TBL] [Abstract][Full Text] [Related]
27. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy.
Callery MP; Pratt WB; Kent TS; Chaikof EL; Vollmer CM
J Am Coll Surg; 2013 Jan; 216(1):1-14. PubMed ID: 23122535
[TBL] [Abstract][Full Text] [Related]
28. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
Tilak M; Tewari M; Shukla HS
Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
[TBL] [Abstract][Full Text] [Related]
29. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
[TBL] [Abstract][Full Text] [Related]
30. Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy.
Ansorge C; Strömmer L; Andrén-Sandberg Å; Lundell L; Herrington MK; Segersvärd R
Br J Surg; 2012 Aug; 99(8):1076-82. PubMed ID: 22556164
[TBL] [Abstract][Full Text] [Related]
31. Rapid postoperative reduction in prognostic nutrition index is associated with the development of pancreatic fistula following distal pancreatectomy.
Sato N; Mori Y; Minagawa N; Tamura T; Shibao K; Higure A; Yamaguchi K
Pancreatology; 2014; 14(3):216-20. PubMed ID: 24854618
[TBL] [Abstract][Full Text] [Related]
32. Mean--and the reporting of continuous data.
Søreide JA
Dig Surg; 2013; 30(4-6):330. PubMed ID: 24030358
[No Abstract] [Full Text] [Related]
33. The efficacy of the prophylactic use of octreotide after a pancreaticoduodenectomy.
Moon HJ; Heo JS; Choi SH; Joh JW; Choi DW; Kim YI
Yonsei Med J; 2005 Dec; 46(6):788-93. PubMed ID: 16385654
[TBL] [Abstract][Full Text] [Related]
34. [The clinical value of pancreatic fistula risk predicting system after pancreaticoduodenectomy].
Yang J; Huang Q; Lin X; Liu C; Hu J; Li R; Wang C
Zhonghua Wai Ke Za Zhi; 2015 Jun; 53(6):410-4. PubMed ID: 26359052
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of postoperative pancreatic fistula.
Facy O; Chalumeau C; Poussier M; Binquet C; Rat P; Ortega-Deballon P
Br J Surg; 2012 Aug; 99(8):1072-5. PubMed ID: 22539219
[TBL] [Abstract][Full Text] [Related]
36. Chylous ascites after hepatopancreatobiliary surgery.
Kuboki S; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
Br J Surg; 2013 Mar; 100(4):522-7. PubMed ID: 23288577
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin analogues for pancreatic surgery.
Gurusamy KS; Koti R; Fusai G; Davidson BR
Cochrane Database Syst Rev; 2012 Jun; (6):CD008370. PubMed ID: 22696379
[TBL] [Abstract][Full Text] [Related]
38. Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial.
Fujii T; Nakao A; Murotani K; Okamura Y; Ishigure K; Hatsuno T; Sakai M; Yamada S; Kanda M; Sugimoto H; Nomoto S; Takeda S; Morita S; Kodera Y
Ann Surg Oncol; 2015 Nov; 22(12):3905-12. PubMed ID: 25777090
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.
El Nakeeb A; ElGawalby A; A Ali M; Shehta A; Hamed H; El Refea M; Moneer A; Abd El Rafee A
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):59-63. PubMed ID: 29428106
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of early drain removal and triple-drug therapy to prevent pancreatic fistula after distal pancreatectomy.
Adachi T; Kuroki T; Kitasato A; Hirabaru M; Matsushima H; Soyama A; Hidaka M; Takatsuki M; Eguchi S
Pancreatology; 2015; 15(4):411-6. PubMed ID: 26073457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
